GlassScriptPhysician profile
Barbara Mclaren
NPI 1437231479
$1,677.98
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $399 · 2021: $301 · 2022: $55.17 · 2023: $19.30 · 2024: $20.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $828.80 | 2019-2024 | |
| Therapeuticsmd, INC. | $268.56 | 2019-2020 | |
| Myovant Sciences INC. | $140.14 | 2021 | |
| Medical Device Business Services, INC. | $95.40 | 2019 | |
| Intuitive Surgical, INC. | $61.09 | 2019 | |
| Mylan Pharmaceuticals INC. | $38.94 | 2019-2020 | |
| Pfizer INC. | $38.35 | 2019-2021 | |
| Duchesnay USA Incorporated | $29.91 | 2019 | |
| Lupin INC. | $28.53 | 2019 | |
| Avion Pharmaceuticals | $27.66 | 2019-2021 | |
| Hologic Sales and Service, LLC | $24.76 | 2021 | |
| Covidien LP | $17.28 | 2020 | |
| Shield Therapeutics INC | $16.81 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.69 | 2019 | |
| Merck Sharp & Dohme LLC | $13.33 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11.85 | 2022 | |
| Minerva Surgical, INC | $11.44 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Mclaren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.